Page last updated: 2024-10-29

ipriflavone and Osseous Paget's Disease

ipriflavone has been researched along with Osseous Paget's Disease in 4 studies

ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.

Research Excerpts

ExcerptRelevanceReference
"Ipriflavone, an isoflavone synthesized from the soy isoflavone daidzein, holds great promise in the prevention and treatment of osteoporosis and other metabolic bone diseases."4.80Ipriflavone: an important bone-building isoflavone. ( Head, KA, 1999)
"Ipriflavone (IP) is an isoflavone derivative available in several countries for investigational and/or therapeutic use."2.38Ipriflavone: pharmacological properties and usefulness in postmenopausal osteoporosis. ( Reginster, JY, 1993)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reginster, JY1
Head, KA1
Agnusdei, D1
Camporeale, A1
Gonnelli, S1
Gennari, C1
Baroni, MC1
Passeri, M1
Bisbocci, D1
Gallo, V1
Damiano, P1
Cantoni, R1
Suriano, A1
Chiandussi, L1

Reviews

2 reviews available for ipriflavone and Osseous Paget's Disease

ArticleYear
Ipriflavone: pharmacological properties and usefulness in postmenopausal osteoporosis.
    Bone and mineral, 1993, Volume: 23, Issue:3

    Topics: Animals; Bone Resorption; Clinical Trials as Topic; Disease Models, Animal; Female; Humans; Hyperpar

1993
Ipriflavone: an important bone-building isoflavone.
    Alternative medicine review : a journal of clinical therapeutic, 1999, Volume: 4, Issue:1

    Topics: Bone Remodeling; Drug Therapy, Combination; Female; Humans; Hyperparathyroidism; Isoflavones; Osteit

1999

Trials

1 trial available for ipriflavone and Osseous Paget's Disease

ArticleYear
Short-term treatment of Paget's disease of bone with ipriflavone.
    Bone and mineral, 1992, Volume: 19 Suppl 1

    Topics: Administration, Oral; Aged; Alkaline Phosphatase; Bone and Bones; Creatinine; Double-Blind Method; F

1992

Other Studies

1 other study available for ipriflavone and Osseous Paget's Disease

ArticleYear
[Paget's disease: the prospects with ipriflavone].
    Recenti progressi in medicina, 1992, Volume: 83, Issue:12

    Topics: Aged; Bone Remodeling; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Isoflavones; Male;

1992